ISO 10993-7:2026

Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals Published (Edition 3, 2026)

Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals Published (Edition 3, 2026)

Digital Document2026Purchase Options

Referenced standards

ISO 10993-17:2023ISO 10993-18:2020ISO 10993-1:2025ISO 10993-23:2021ISO 11139:2018ISO 11979-5ISO 14971:2019
Unit Price
USD231.03Save 20%
USD 288.79

PREVIEW

ISO 10993-7:2026

Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals Published (Edition 3, 2026)

Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals Published (Edition 3, 2026)

Abstract

This document specifies allowable limits (AL) for residual ethylene oxide (EO) and ethylene chlorohydrin (ECH) in EO-sterilized medical devices, procedures for the measurement of EO and ECH, and methods for determining conformity so that devices can be released. Additional background, including guidance and a flowchart showing how this document is applied, are also included in Annexes A, B, C, D, E, F, G, H, I, J and K.

EO-sterilized devices or components that have neither direct nor indirect body or user contact (e.g. in vitro diagnostic devices) are out of scope of this document. This document does not apply to devices that have been demonstrated to not absorb or retain EO or its degradation product ECH, such as medical devices made exclusively of metal alloys and glass, see Clause C.5[228].

NOTE            This document does not specify limits for ethylene glycol (EG). No device limits are specified for EG because the risk assessment in Annex F indicates that calculated allowable levels are higher than those likely to occur in a medical device.

General information